Prime editing: The state-of-the-art of genome editing

Khatami, Fatemeh; Aghaii, Maryam; Aghamir, Seyed Mohammad Kazem

doi:10.1016/j.mgene.2020.100661

Cited by 3 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1B). 10,18 Flap equilibration The flap equilibration is the process that occurs after the RT has edited the target DNA sequence, and two singlestranded DNA flaps are left-the 5' and 3' flaps, unedited and edited DNA strands, respectively. 1 Cellular DNA repair processes excise the 5' flap, allowing the 3' flap to be introduced into the target site generating a heteroduplex DNA, containing the edited and the nonedited strands.…”

Section: Advantages Of Prime Editing Over Conventional Crispr-cas9mentioning

confidence: 99%

Prime Editing, a Novel Genome-Editing Tool That May Surpass Conventional CRISPR-Cas9

Ochoa-SanchezAdriana

Perez-SanchezGabriela

Marianna

et al. 2021

Re:GEN Open

View full text Add to dashboard Cite

Background: Genome editing mediated by clustered regularly interspaced short palindromic repeat -CRISPR-Cas-was first reported using cell lines in 2012, and since then, its applications in other systems have steadily increased. However, this approach still needs improvement and optimization. Prime Editing (PE) was originally proposed by Anzalone and colleagues in 2019, who showed significant lower rates of "off target" effects compared to conventional CRISPR-Cas9. Objectives: In this review, we describe and compare the "conventional" CRISPR-Cas9 system with a novel homology-directed repair-independent editing approach called Prime Editing (PE). Methods: Numerous recent publications involving the PE molecular mechanism for targeted-mutagenesis, advantages, limitations, and applications of the approach in different biomedicine fields were reviewed. Results: From the literature, it appears that PE neither relies on DSB nor needs HDR with exogenous donor DNA templates, which shows the clinical potential of PEs in correcting a broad range of mutations for genetic diseases. Four generations of PE mechanisms have been developed, reaching higher efficiency from one generation to the next one. However, reviewed studies support that PE also introduces new challenges such as unwanted mutations mediated by the double nicking strategy required for the PE3's efficiency, the selection of the optimal combination of PBS and RT templates, and the limitation of large DNA insertions that conventional CRISPR-Cas9 is capable of. Conclusion:The reviewed literature demonstrate that genome editing-based PE is a promising technology aiming at decreasing the common undesirable effects associated with conventional genome editing approaches such as CRISPR-Cas9 or BE. Even though progress has been made to improve the efficiency of the genome editing by the PE ribonucleo-protein complex, further research is required to optimize PE tools and maximize its efficiency.

show abstract

Section: Advantages Of Prime Editing Over Conventional Crispr-cas9mentioning

confidence: 99%